Perfil
Xavier Avat, former Head of Corporate Development at Gilead Sciences, Inc., served as the SVP of Global Corporate Strategy & New Initiatives at Edwards Lifesciences Corp.
He also held the position of Vice President of Corporate Development at Santen Pharmaceutical Co., Ltd.
In 2022-2023, Avat worked as the Chief Business Officer at Capricor Therapeutics, Inc. Avat graduated from Ecole Polytechnique Universitaire de Lille and holds an MBA from École des Hautes Études Commerciales du Nord.
Antiguos cargos conocidos de Xavier Avat.
| Empresas | Cargo | Fin |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2023 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
| EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | - |
Formación de Xavier Avat.
| École des Hautes Études Commerciales du Nord | Masters Business Admin |
| Ecole Polytechnique Universitaire de Lille | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Xavier Avat
